🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#Fara_Friday at Asklepios #EP_Altona. Today: #PFA based PVI after #LAAC ✅ Great collaboration with Maxim Didenko, MD PhD Philipp Sommer Christian Sohns Enjoy the Video! 🎥 🚨⚡️⚡️ Roland Tilz Julian Chun Serge Boveda Prof Dhiraj Gupta Arian Sultan Melanie Gunawardene Christian Sticherling

curzen SUPER conservative 1ry end point here: recurrence of ANY atrial arrhythmia for 30s Only 15% of PFA patients had a redo, 10% of cryo. 3% in each arm needed antiarrhythmic drug. Ok I’m biased (I do ablation) but >80% in both arms doing great clinically at 1 year.

curzen Dr Malcolm Finlay AF burden is usually down 98-99% as per Jason Andrade has shown. Many of your stented patients likely still use occasional GTN spray - do you consider them a failure? Traditional reporting of AF success means the interventional community undervalue/under-refer 4 this procedure

Re Ablation - we know ablation 1. is the most effective method of preventing arrhythmia recurrence. 2. substantially improves QOL and symptoms (vs sham) 3. Significant reduces health care utilisation and cost 4. Is a disease modifying intervention

curzen You should read the paper! Not symptomatic AF but AF on continuous monitoring. The strong point that this study shows is really how effective both forms of AF ablation are - such a low AF burden using continuous monitoring. Below a slide from my commentary on the presentation

Exciting news! Professor Tolga Aksu, MD's live case session from EHRA 2025 is now available to rewatch! Witness a real-time #CardioneuralAblation in a patient with recurrent vasovagal syncope, and see how #inHEART’s advanced 3D imaging technology can support your CNA procedures.

Very encouraging to see our collective improvements in VT ablation success. VT ablation should and will have a 90% success rate like SVT because we understand its mechanism with sinus surrogates. AF has a plateau at 80%, in need for new mechanistic insights. #ablateVT

❓ How good are we as cardiologists at modifying lifestyle and risk factors in patients with atrial fibrillation? 🫀 🏃 🍔 ➡️ Check out the results of our EHRA survey published in Europace: academic.oup.com/europace/artic… Take home messages discussed below 🧵 Europace Editor-in-Chief 1/n

#EPeeps Remember the previous excitement around the radiofrequency balloon catheter? What ever happened to it? 🔥 🎈 Check out our article in Indian Pacing and Electrophysiology Journal. Link: sciencedirect.com/science/articl… Prof Dhiraj Gupta

#EHRA_ESC Survey on Cardioneuroablation: Key Insights! 🌍 202 participants from 40 countries 🎯 71% of responders target GPs systematically in both RA and LA; 16% ablate LA GPs only in no response after ablation in RA 🫀 90% rely on anatomical approach, 📈 59% prefer

Let’s talk about the Top 10 cardiology papers of 2024 that shook up the field! Hard science, no BS, 🚀 and yes — some practices WILL change. 🫀 Let’s dive in: a tweetorial thread! #CardioTwitter #MedEd #Cardiology

#DGKJahrestagung #HRS2025 Another output of our #TeleCheckAF project… And it goes on and on 🙂👍🏻 Henrike Hillmann Astrid Hermans MonikaGawalko Konstanze Betz Prof Dhiraj Gupta RachelvdVelden Emma Sandgren Dominique Verhaert Arian Sultan Jeroen Hendriks Daniel Scherr

What do you get when a bunch of electrophysiologists open at a conference? Presenting the Dysrhythmics! Here’s a sneak peek of the #HRS2025 opening ceremony —EPs doing more than just ablations. Join us Thursday, 4/24 at 5 p.m. at the Sails pavilion Heart Rhythm Society Mayo Clinic CV

#DGKJahrestagung The AFNET Lecture “Nipping #AFib in the Bud“ Given by THE Prof J Camm 👏 Great summary of early rhythm control… 👉🏻with focus on patients with acute, early, recent onset AF… - EAST AFNET 4 💊 - EARLY-AF 🔥 - Adding early risk factor modification

It’s amazing to see consistent information across populations Recapitulating data from CIRCA-DOSE the recent Advantage AF showed AF burden <0.1% & AF episodes less <1h on follow-up had HCU comparable to no AF Same threshold paroxysmal and Persistent AF shorturl.at/gBxXb

Thrilled to have been part of this study. Thanks Roderick Tung for including Daniel Alyesh, myself and South Denver Cardiology

ADVANTAGE AF, the first large prospective study of #PFA to treat PerAF using a PVI and posterior wall isolation strategy, revealed favorable safety and effectiveness outcomes. Get the details: jacc.org/doi/10.1016/j.… #JACC #AFib Vivek Y. Reddy

Marshall-PLAN (PVI + VOM ethanol infusion + systematic anatomic linear partition) does better than PVI only at 1 year and respects atrial physiology #AHAJournals #Epeeps @EPBordeaux Marine Arnaud Chris Kowalewski MD doi.org/10.1161/CIRCEP…

Ablation of atrial fibrillation and risk of stroke: a Meta-analysis #OpenAccess Rui Providência @UCL Imperial College London Barts Health heartrhythmjournal.com/article/S1547-…